Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 885825 | ISIN: US4525253062 | Ticker-Symbol: IUL
Frankfurt
28.03.24
08:00 Uhr
4,820 Euro
+0,120
+2,55 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
IMMUCELL CORPORATION Chart 1 Jahr
5-Tage-Chart
IMMUCELL CORPORATION 5-Tage-Chart

Aktuelle News zur IMMUCELL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.03.IMMUCELL CORP /DE/ - 8-K, Current Report1
01.03.Earnings call: ImmuCell sees recovery in Q4 amid 2023 challenges1
29.02.ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript1
27.02.ImmuCell GAAP EPS of -$0.15, revenue of $5.09M1
27.02.ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 202362PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
27.02.IMMUCELL CORP /DE/ - 8-K, Current Report1
16.02.ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 20231
08.01.ImmuCell says total sale for year ended December falls 6% Y/Y1
08.01.ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023443PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
08.01.IMMUCELL CORP /DE/ - 8-K, Current Report1
13.11.23ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 202358PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
13.11.23IMMUCELL CORP /DE/ - 8-K, Current Report1
07.11.23ImmuCell Corporation: ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 20231
05.10.23ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023247PORTLAND, Maine, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
11.07.23ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023335PORTLAND, Maine, July 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
21.06.23ImmuCell Corporation: ImmuCell Appoints Bryan K. Gathagan to Board of Directors626PORTLAND, Maine, June 21, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
15.06.23ImmuCell Corporation: ImmuCell Announces Approval of Principal Terms of a $3 Million Debt Facility380PORTLAND, Maine, June 15, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
11.05.23ImmuCell Corporation: ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023242PORTLAND, Maine, May 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically...
► Artikel lesen
05.04.23ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023907PORTLAND, Maine, April 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-proven...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1